
Tusk Venture Partners
Description
Tusk Venture Partners, based in New York City, is a distinctive early-stage venture capital firm specializing in technology companies operating within heavily regulated sectors. Founded by political strategist Bradley Tusk, the firm leverages its deep expertise in government relations and public affairs to support startups navigating complex legal and policy landscapes. Their unique value proposition lies in helping portfolio companies not just build innovative products, but also strategically engage with regulators and policymakers, often turning regulatory hurdles into competitive advantages.
Tusk Venture Partners primarily targets seed and Series A stage companies across various industries, including fintech, healthtech, mobility, and proptech. Their investment thesis is rooted in the belief that regulatory challenges, while daunting, can be overcome with the right strategic guidance. The firm has steadily grown its capital base, with its most recent vehicle, Tusk Venture Partners Fund III, closing at $100 million in 2022. This growth reflects their continued commitment to and success in this specialized niche.
The firm typically deploys initial investments ranging from $1 million to $5 million, providing crucial capital for early-stage companies to scale and address regulatory complexities. Beyond capital, Tusk Venture Partners offers hands-on support in areas such as lobbying, public relations, and legal strategy, which are critical for startups disrupting established industries. Their portfolio includes notable companies like Bird, Lemonade, and Latch, demonstrating their ability to identify and nurture ventures poised for significant impact despite regulatory headwinds. This bespoke support system differentiates them from traditional VC firms, making them a strategic partner for founders in regulated markets.
Investor Profile
Tusk Venture Partners has backed more than 77 startups, with 3 new investments in the last 12 months alone. The firm has led 12 rounds, about 16% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Financial Services, Medical.
- Typical check size: $1M – $5M.
Stage Focus
- Series A (31%)
- Seed (26%)
- Series B (17%)
- Series C (8%)
- Series Unknown (5%)
- Pre Seed (4%)
- Series D (4%)
- Series E (3%)
- Angel (1%)
- Debt Financing (1%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Financial Services
- Medical
- Fintech
- Wellness
- Software
- Consumer Goods
- Transportation
- Health Diagnostics
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.